Squarepoint’s Ultralife ULBI Stock Holding History

Squarepoint’s Portfolio ULBI Stock Details ULBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-13,824	Closed	-$79.1K	–	5004
2025 Q4	$79.1K	Sell	13,824 -2,117	-13%	-$13.1K	﹤0.01%	4077
2025 Q3	$109K	Buy	+15,941	New	+$121K	﹤0.01%	4097
2025 Q2	–	Sell	-37,211	Closed	-$200K	–	5083
2025 Q1	$200K	Sell	37,211 -5,050	-12%	-$34.3K	﹤0.01%	4014
2024 Q4	$315K	Buy	42,261 +13,538	+47%	+$111K	﹤0.01%	4113
2024 Q3	$260K	Buy	28,723 +18,723	+187%	+$193K	﹤0.01%	3544
2024 Q2	$106K	Sell	10,000 -3,898	-28%	-$41.5K	﹤0.01%	3787
2024 Q1	$122K	Buy	+13,898	New	+$113K	﹤0.01%	3751
2021 Q2	–	Sell	-13,255	Closed	-$110K	–	3716
2021 Q1	$110K	Buy	+13,255	New	+$94K	﹤0.01%	2876
2019 Q4	–	Sell	-11,950	Closed	-$103K	–	2821
2019 Q3	$103K	Sell	11,950 -7,102	-37%	-$60.8K	﹤0.01%	2187
2019 Q2	$151K	Buy	+19,052	New	+$173K	﹤0.01%	2160

Other funds holding ULBI

VWA

Visionary Wealth Advisors O'fallon, Illinois $2.26B AUM 19.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

THC

Truffle Hound Capital Bethesda, Maryland $386M AUM 57.88% 1-Year Est. Return

RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Squarepoint's ULBI Position: Q1 2026 in Review

Squarepoint sold out of Ultralife (ULBI) in Q1 2026, closing a stake of 13,824 shares — an estimated $79.1K sold.

Squarepoint first reported a position in ULBI in Q2 2019 and held it in 10 quarters. The position peaked at $315K in Q4 2024. 50 funds tracked by Wall St. Rank hold ULBI as of Q1 2026.

Squarepoint reported no remaining Ultralife position as of Q1 2026 after selling out during the quarter.
Squarepoint sold 13,824 Ultralife shares in Q1 2026, an estimated $79.1K.
Squarepoint first reported a position in Ultralife in Q2 2019 and held it in 10 quarters.
Squarepoint's Ultralife position peaked at $315K in Q4 2024.
50 funds tracked by Wall St. Rank held Ultralife as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.